InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receive First Payment on ‘Milestone’ Purchase of Cancer Detection Equipment
March 7, 2023
AnPac Bio-Medical Science (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection, received the first payment in late February 2023 from a Malaysian customer that had purchased AnPac Bio’s Model AP9080 cancer detection devices. The contract for these devices totaled $1.5 million. According to the announcement, the proprietary Model AP9080 features […]
Lexaria Bioscience Corp. (NASDAQ: LEXX), a Global Innovator in Drug Delivery Platforms, Holds Discussions With Several Larger Companies on Path to Commercialization of DehydraTECH(TM) Technology
March 7, 2023
In 2022, Lexaria Bioscience (NASDAQ: LEXX), a global innovator developing and commercializing its patented DehydraTECH(TM) drug delivery technology, achieved several important goals for the year, according to CEO Chris Bunka. “One of our biggest achievements of 2022 was our greater emphasis on commercial pursuits,” Bunka wrote in his January 2023 letter to shareholders (https://ibn.fm/SPqK7). This […]
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Retains Top Banking Firm to Support Growth, Revenue-Generating Strategy
March 3, 2023
Aditxt Inc. (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, announced that it is working with Riverside Management Group LLC, a merchant banking firm providing investment banking advisory services; RMG will be supporting Aditxt’s strategic growth and revenue generating plans for its subsidiary Pearsanta Inc., […]
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Q4 and FY 2022 Results Call
March 2, 2023
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, today announced its plans to host a conference call to discuss its results for the fourth quarter and full fiscal year ended Dec. 31, 2022. The call is scheduled to start […]
InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Featured in New Goldman Small Cap Research Report
March 1, 2023
QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases and conditions, is spotlighted in a new opportunity research report released by Goldman Small Cap Research. A stock market research company specializing in the small cap and microcap sectors, Goldman reviewed QSAM’s […]
D-Wave Quantum Inc. (NYSE: QBTS) Announces Product and Business Updates, Including AI/Machine Learning Offering and Expansion of Quantum Cloud Service to Israel
March 1, 2023
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services is transforming multiple industries as the world’s first commercial supplier of quantum computing solutions. D-Wave recently announced a series of product and business updates demonstrating the company’s continued progress and the momentum of its leadership in driving quantum commercialization, including a broad […]
Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) Kicks Off New Year with New Look
March 1, 2023
Cerberus Cyber Sentinel (NASDAQ: CISO) is starting off the new year with a new name, brand and logo (https://ibn.fm/Mxai7). The company, which has established itself as a leading cybersecurity and compliance provider, has announced plans for a corporate rebrand and launch designed to reflect the company’s global mission. “At the heart of the rebranding is […]
InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Announces Completion of Enrollment for Phase 1 CycloSam Study
February 28, 2023
QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases and conditions, has completed enrollment in its first participant grouping, or cohort, for its upcoming phase 1 study. The study is designed to evaluate CycloSam in the treatment of bone cancer. The […]
D-Wave Quantum Inc. (NYSE: QBTS) Highlights Commercial Customer Engagements and Cross-Platform Product Enhancements During Qubits 2023 Convention
February 24, 2023
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced new and renewed commercial customer engagements and product updates for its annealing and gate-model quantum computing solutions during the company’s annual Qubits 2023 user conference. The company’s continued commercial customer momentum and […]
InvestorNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Begins Trading on Toronto Stock Exchange
February 23, 2023
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) has obtained conditional approval to list its common shares on the Toronto Stock Exchange (“TSX”). According to the announcement, Eloro shares will trade under the trading symbol: ELO. The announcement also noted that the listing is subject to Eloro Resources fulfilling certain requirements of the TSX; those […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Plan to Streamline Efforts, Maximize Efficiency, Focus on Clinical Trials
February 23, 2023
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced a strategic plan designed to streamline efforts, maximize operating efficiency and focus on critical clinical trials, including near-term, mid-term and long-term milestones. A part of that plan was the release of an estimated 15% of Cybin’s workforce, including those […]
IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Return of Dr. Alan Baratz, CEO of D-Wave Quantum Inc.
February 22, 2023
LOS ANGELES, Feb. 22, 2023 (GLOBE NEWSWIRE) — via InvestorWire — IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]
InvestorNewsBreaks – Infinity Stone Ventures Corp. (CSE: GEMS) (OTC: GEMSF) (FSE: B2I) Eyes Dual Listing to Reach Untapped International Market
February 21, 2023
Infinity Stone (CSE: GEMS) (OTC: GEMSF) (FSE: B2I) today announce that it has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex and MERJ Exchange Limited. The planned dual listing is designed to provide the company with the opportunity to […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Prioritizes Development of Next Generation Chemotherapies
February 21, 2023
Processa Pharmaceuticals (NASDAQ: PCSA) today reiterates the strategic prioritization of its pipeline of proprietary oncology drugs, defined as Next Generation Chemotherapies (“NGCs”). According to the update, previous studies with these NGCs suggest potential improvement in the safety-efficacy profile, significantly differentiating these NGCs from their three presently widely used counterparts – capecitabine, gemcitabine and irinotecan. “The […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Foster New Partnerships with its Expanding DehydraTECH(TM) Licensing Opportunities
February 21, 2023
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has, since 2016, repeatedly demonstrated the potential of its patented technology, DehydraTECH(TM). The technology improves how active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods while increasing the effectiveness of fat-soluble active molecules. With the help of this technology, Lexaria […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report
February 21, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on its second quarter of fiscal year 2023, the period that ended Dec. 31, 2022. Highlights of the report include the company closing the calendar year with nearly $11.5 million in cash and the […]
InvestorNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Targeting Ambitious Development Milestones in 2023
February 17, 2023
Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a developer of next-gen technologies for EV powertrains and grid-connected renewable energy systems, remains committed to building momentum gained in 2022. “As the previous year drew to a close, this developer of transformative power conversion technologies and control system solutions for modern electrical systems validated its zero-voltage switching (‘ZVS’) inverter […]
Commercial Quantum Computing Center Stage at D-Wave Quantum Inc. (NYSE: QBTS) Qubits23 Conference
February 16, 2023
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering practical quantum applications, and the only provider building both annealing and gate-model quantum computers, recently held its Qubits23 user conference in Miami, Florida. Providing valuable information, demos, and scientific talks, the conference served as an important opportunity for attendees […]
AmeriCann Reports Four Consecutive Quarters of Positive Net Income
February 16, 2023
DENVER, Feb. 16, 2023 (GLOBE NEWSWIRE) — via InvestorWire — AmeriCann Inc. (OTCQB: ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, has released financial and operational results for its quarter ending December 2022. “AmeriCann’s focus on financial performance has produced excellent results, with four consecutive quarters of positive […]
InvestorNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Lead NanoAb Candidate Demonstrates Significant Advantages
February 15, 2023
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently achieved key milestones. These include the demonstration of statistically significant positive results from a preclinical in-vivo proof-of-concept study of its inhaled anti-COVID-19 nanosized antibodies (“NanoAbs”). “Its lead NanoAb candidate, designed […]
InvestorNewsBreaks – Sugarmade Inc. (SGMD) Releases Letter to Shareholders, Corporate Update
February 15, 2023
Sugarmade (OTC: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, today issued a letter to shareholders from its Chief Executive Officer Jimmy Chan. “Pivoting toward new opportunities is an essential element of good stewardship, and Sugarmade continues to welcome favorable developments in its corporate structure. While the optics […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Closes on $6.25M Registered Direct Offering
February 15, 2023
Processa Pharmaceuticals (NASDAQ: PCSA), a diversified clinical-stage company developing next-generation chemotherapy drugs for patients who have unmet medical conditions and/or require better treatment options to improve a patient’s survival and/or quality of life, announced that it has closed on its registered direct offering. The company noted that the $6.25 million offering included definitive agreements with […]
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Mat Sorensen, Author of The Self Directed IRA Handbook
February 15, 2023
LOS ANGELES, Feb. 15, 2023 (GLOBE NEWSWIRE) — via InvestorWire — IBN, a multifaceted communications organization engaged in connecting companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates and […]
InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Q1 2023 Fiscal, Business Report
February 15, 2023
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on its fiscal first quarter for the period ending Dec. 31, 2022. Highlights of the report include the following: acquiring the assets of Electric Last Mile Solutions (“ELMS”) in a $105 million acquisition move; $100 million in cash being available for operations and […]
InvestorNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Releases Financial Report, Corporate Update for Q3
February 15, 2023
India Globalization Capital (NYSE American: IGC) (dba IGC Inc.) is reporting on its financial and corporate performance for the third fiscal quarter 2023. Highlights of the report include a focus on the company’s phase 2 clinical trial on IGC-AD1 for agitation in dementia from Alzheimer’s disease. The company reports that the number of sites participating […]
Sugarmade (SGMD) Issues Shareholder Letter and 2023 Corporate Update
February 15, 2023
NEW YORK, Feb. 15, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Sugarmade, Inc. (OTC Pink: SGMD) (“Sugarmade,” “SGMD” or the “Company”), a product and branding marketing company investing in operations and technologies with disruptive potential, is pleased to issue the following letter to shareholders from Chief Executive Officer Jimmy Chan. Dear Valued Shareholder, Pivoting toward […]
IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022
February 15, 2023
IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022 POTOMAC, Md., Feb. 14, 2023 (GLOBE NEWSWIRE) — via InvestorWire — India Globalization Capital, Inc. (dba IGC, Inc.) (NYSE American: IGC) (“IGC” or the “Company”) today reported its third fiscal quarter 2023 financial results. Third Fiscal Quarter 2023 Highlights: Ram Mukunda, CEO of […]
Mullen Automotive Provides Fiscal First Quarter 2023 Business Update
February 15, 2023
BREA, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a financial update for its fiscal first quarter in 2023 ending December 31, 2022. Fiscal First Quarter 2023 and Recent Highlights Include: Management Commentary “In a very short period of time […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Q3 Financial Report, Corporate Highlights
February 14, 2023
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), is reporting on its third quarter performance as well as recent business highlights; the report is for the period ended Dec. 31, 2022. In the report, the company noted that it had received approval from an independent ethics committee in the […]
InvestorNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Completes Acquisition of the Bahia Project
February 13, 2023
Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced completion of its acquisition of 17 mineral concessions between the towns of Prado and Caravelas in the state of Bahia, Brazil, totaling 15,089.71 hectares (approximately 37,300 acres or 58.3 square miles). According to the announcement, closing of the “Bahia Project” followed the Brazilian Government’s approval of […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces $6.25M Registered Direct Offering
February 10, 2023
Processa Pharmaceuticals (NASDAQ: PCSA) is a diversified clinical-stage company developing next generation chemotherapy drugs for patients who have unmet medical conditions and/or require better treatment options to improve a patient’s survival and/or quality of life. The company today announced its entry into definitive agreements with retail investors for the purchase and sale of 7,812,544 common […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) Expecting Additional Growth in 2023, Including IND Filing and IND Clinical Study
February 10, 2023
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has released its new corporate presentation (https://ir.lexariabioscience.com/presentations). The presentation augments the positive outlook for the coming year put forth in an earlier released shareholder update letter from the company’s CEO, Chris Bunka. Bunka starts the letter with, “As 2022 came to a close, it […]
InvestorNewsBreaks – Hillcrest Energy Technologies Ltd.’s (CSE: HEAT) (OTCQB: HLRTF) Major Advancement Toward Commercialization Featured in Research Report
February 9, 2023
Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, was the subject of an updated report by Singular Research released in early January. Singular previously speculated on the prospects of Hillcrest’s “potential breakthrough” inverter technology and how it could attract the attention […]
InvestorNewsBreaks – Standard Lithium Ltd. (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L) Announces Fiscal Q2 Results, Continues to Advance Commercial Development Strategy
February 9, 2023
Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, today released its financial and operating results for the fiscal second quarter ended Dec. 31, 2022. “Standard Lithium continues to advance its commercial development strategy and recently achieved several significant milestones,” said CEO and Director Robert Mintak. “Most notably, we completed […]
InvestorNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Receives $24M Investment from Leading Global Mining Company
February 8, 2023
Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) has entered into a subscription agreement with Anglo American resulting in an estimated $24 million investment in Canada Nickel; the investment is at a price of $1.95 per common share, representing a 10% premium to the 30-day volume weighted average price (“VWAP”) and making Anglo American a 9.9% shareholder when the transaction is completed. […]
Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Commissions Demonstration Plant; Plans for Louisiana Strategic Metals Complex
February 8, 2023
Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company focused on Rare Earth Element (“REE”) resource development and precious metal commercialization, recently provided an update on the commissioning process for its RapidSX(TM) Demonstration Plant for the separation of heavy and light REEs. The demonstration plant is located within Ucore’s 5000 square foot RapidSX(TM) Commercialization and […]
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Q3 2023 Financial Results, Corporate Update
February 8, 2023
VistaGen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, is reporting on its fiscal year 2023 third quarter ended December 31, 2022; the report also included corporate highlights for the same period. According to the report, […]
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Receives Health Canada Regulatory Approval to Move Forward with Phase 1 Trial
February 7, 2023
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, has received notification that it can move forward with its proposed phase 1 clinical trial in Canada. The notification came in the form […]
IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Stuart Gray, President of ‘Metaverse-as-a-Service’ Pioneer Utopia VR
February 7, 2023
LOS ANGELES, Feb. 07, 2023 (GLOBE NEWSWIRE) — via InvestorWire — IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]
SideChannel Inc. (SDCH) Bringing Critical Security to Clients with Tailored Cybersecurity Programs for Mid-Market Companies
February 7, 2023
During his stints at the US Department of Defense (“DoD”) and Pentagon, and later upon entry into corporate America, Brian Haugli made an observation: US Government agencies and, crucially, large American corporations, relied on mid-market companies, innovative startups, and smaller organizations for important products and services. This reliance often meant that the security posture of […]